Literature DB >> 280713

Ultrastructure of 1,2-dimethylhydrazine-induced adenocarcinomas in rat colon.

D H Barkla, P J Tutton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 280713     DOI: 10.1093/jnci/61.5.1291

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Antiproliferative and apoptotic-inducing potential of ellagic acid against 1,2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats.

Authors:  Syed Umesalma; Ponnuraj Nagendraprabhu; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

2.  Premalignant alterations in the lipid composition and fluidity of colonic brush border membranes of rats administered 1,2 dimethylhydrazine.

Authors:  T A Brasitus; P K Dudeja; R Dahiya
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Tuft (caveolated) cells in two human colon carcinoma cell lines.

Authors:  D H Barkla; R H Whitehead; H Foster; P J Tutton
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

4.  Gut endocrine cells in rat intestinal-tract carcinoma induced by 1,2-dimethylhydrazine.

Authors:  F Shimamoto; E Tahara; N Yanaihara
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Neuroendocrine cells within colorectal tumours induced by dimethylhydrazine. An immunocytochemical study.

Authors:  C F Johnston; A B O'Neill; M M O'Hare; K D Buchanan
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

6.  Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa.

Authors:  R F Jacoby; X Llor; B B Teng; N O Davidson; T A Brasitus
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Colonic perianastomotic carcinogenesis in an experimental model.

Authors:  Sergio Pérez-Holanda; Luis Rodrigo; Carme Pinyol-Felis; Joan Vinyas-Salas
Journal:  BMC Cancer       Date:  2008-07-31       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.